David Parker

This inventor holds 20 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Lanthanide Complexes. Top assignees: Celltech Limited, Celltech Therapeutics Limited, University of Durham. Active years: 1991-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Parker. Retrieved from https://idiyas.com/inventor/david-parker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 2)

% Patents Active = 85.0

CIPO Patents = 2

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 2.8

ph-index = 9

Forward Citations = 201(Granted Patents)

Location History:

Durham City, GB (2013)
Durham, GB (1991 - 2018)

Company Filing History:

Celltech Therapeutics Limited

Centre National De La Recherche Scientifique

Ecole Normale Superieure De Lyon

patents

10. 1 out of 45

Johannes Gutenberg-Universität Mainz

patents

11. 1 out of 8

Mds Analytical Technologies (US) Inc.

patents

12. 1 out of 33

Sensors for Medicine & Science, Inc.

patents

where one patent can have more than one assignee

Years Active: 1991-2018

Loading Chart...

Areas of Expertise:

Chelating Agents

Luminescent Complexes

Lanthanide

Macrocycles

Fluorescent Detection

Aza-Macrocycles

Lipids

Analyte Detection

Conjugate Compounds

Metal Complexes

Polymerizable Thiophene

Responsive Luminescence

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10130722 - Bifunctional chelating agents based on the 1,4-diazepine scaffold (DAZA) for non-invasive molecular imaging (2018-11-20),

2. 9920082 - Water-soluble complexing agents and corresponding lanthanide complexes (2018-03-20),

3. 9448225 - Responsive luminescent lathanide complexes (2016-09-20),

4. 9296762 - Complexing agents and corresponding lanthanide complexes (2016-03-29),

5. 8628978 - Responsive luminescent lanthanide complexes (2014-01-14),

6. 8501398 - Luminescence assay using macrocyclic lanthanide (III) complexes (2013-08-06),

7. 7531676 - Lipids (2009-05-12),

8. 7517701 - Luminescent lanthanide complexes (2009-04-14),

9. 6774228 - Tetra-aza macrocycles and metal complexes thereof (2004-08-10),

10. 6583301 - Lipids (2003-06-24),

11. 6344360 - Detection of analytes by fluorescent lanthanide metal chelate complexes containing substituted ligands (2002-02-05),

12. 5684135 - Conjugate compounds containing aza-macro-cycles and processes for their (1997-11-04),

13. 5653960 - Tetra-aza macrocycles, processes for their preparation and their use in (1997-08-05),

14. 5565562 - Triaza macrocycles (1996-10-15),

15. 5484893 - Tri-aza macrocycles and metal complexes thereof (1996-01-16),

Title: The Innovative Journey of David Parker

Introduction: David Parker, a pioneering inventor hailing from Durham, GB, has made significant contributions to the world of innovations with his groundbreaking ideas and inventions.

Latest Patents: David Parker's latest patents include cutting-edge technologies in the field of renewable energy, sustainable agriculture, and advanced materials science, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, David Parker has established himself as a leading figure in the innovation landscape. His work has been recognized globally for its impact on various industries, from healthcare to transportation.

Collaborations: Throughout his career, David Parker has collaborated with top research institutions, universities, and leading companies to bring his inventions to life. His ability to work across disciplines and sectors has led to the development of innovative solutions to complex challenges.

Conclusion: David Parker's passion for innovation and his relentless pursuit of excellence have solidified his position as a visionary inventor. His contributions continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.